NREF Posts Q3 Loss; Q4 CAD Guidance Covers Dividend

NexPoint Real Estate Finance Inc. (NYSE: NREF) reported a third-quarter loss and a 5.2% sequential decline in book value, contrasting with higher net interest income and improved non-GAAP distributable earnings. For the fourth quarter, the mortgage REIT expects cash available for distribution, or CAD, of $0.55 per diluted common share at the midpoint, enough to cover its declared $0.50 dividend, while projected earnings available for distribution, or EAD, would fall short of the payout.

NREF recorded a third-quarter net loss of $0.9 million, compared with net income of $17.3 million in the second quarter. The loss attributable to common stockholders was $12.2 million, or $0.65 per diluted share, reversing second-quarter income attributable to common stockholders of $5.4 million, or $0.29 per diluted share.

Net interest income increased by $0.7 million sequentially to $17.3 million as interest income rose to $27.4 million and interest expense increased to $10.2 million. Other income swung to a loss of $7.4 million from income of $10.8 million in the prior quarter, while operating expenses rose to $10.8 million from $10.0 million.

Book value, including redeemable noncontrolling interests in the operating partnership, declined to $406.1 million, or $17.63 per common share, from $18.60 per share at the end of the second quarter.

Distributable earnings covered the third-quarter dividend

Third-quarter EAD was $12.2 million, or $0.52 per diluted common share, up 13% from the second-quarter per-share result. CAD totaled $14.0 million, or $0.60 per diluted common share, an increase of 3.4% sequentially.

NREF paid a third-quarter dividend of $0.50 per common share on September 30. EAD covered the payout by 1.04 times and CAD by 1.20 times, while GAAP earnings coverage was negative at 1.30 times.

The board declared another $0.50-per-share dividend for the fourth quarter, payable December 31. Management’s fourth-quarter guidance calls for net income attributable to common stockholders of $6.8 million to $9.2 million. At the midpoint, NREF expects EAD of $0.42 per diluted common share and CAD of $0.55, corresponding to dividend coverage of 0.84 times and 1.10 times, respectively. Estimated GAAP earnings coverage is 0.68 times.

EAD and CAD are non-GAAP measures that NREF uses to assess its ability to pay distributions. The per-share calculations use adjusted diluted shares that exclude the potential dilutive effect of settling Series B or Series C preferred-stock redemptions with common shares.

Portfolio remains concentrated in stabilized real estate assets

NREF ended September with an outstanding portfolio of about $1.0 billion across 83 investments. The portfolio includes senior and mezzanine loans, commercial mortgage-backed securities, preferred equity, preferred stock, real estate and other investments tied primarily to multifamily, single-family rental, self-storage, industrial, marina and life-science properties.

Excluding certain equity holdings, credit facilities and directly owned multifamily properties, 78.3% of the portfolio was stabilized. The weighted-average loan-to-value ratio was 64.7%, the weighted-average debt-service coverage ratio was 1.39 times and the average remaining term was 2.4 years. The company said the portfolio has minimal construction-loan exposure and no heavy transitional or for-sale loans.

During the quarter, NREF funded $8.4 million on a loan paying a monthly coupon of SOFR plus 900 basis points. It also funded two preferred-equity investments totaling $6.2 million, with monthly preferred returns of 14% and 13%.

The presentation described a potentially more favorable supply backdrop for several core property types. Multifamily construction starts fell more than 40% between 2023 and 2025, with deliveries forecast to decline to about 327,000 units in 2027 from roughly 600,000 in 2024. Management also expects self-storage fundamentals to strengthen through 2026 as construction pipelines contract.

Life-science real estate continues to face near-term oversupply. NREF said the remaining speculative development pipeline is expected to be delivered through 2026, after which new supply is expected to be largely limited to fully pre-leased build-to-suit projects. The company identified domestic biomanufacturing investment as a source of demand that has partly offset weaker laboratory and research-and-development leasing.

Financing capacity expanded

NREF increased an existing senior secured term loan and total-return swap facility with Mizuho to $450 million from $375 million. The company also raised $27.9 million through the issuance of about 1.1 million Series C preferred shares. Its debt-to-equity ratio was 0.97 times at September 30.

CAD covered combined Series B and Series C preferred dividends by 1.37 times in the third quarter, while the corresponding net-loss coverage ratio was negative at 1.20 times. NREF said it maintains enough liquidity to pay cash for preferred-share redemptions up to the quarterly cap and does not intend to settle Series B or Series C redemptions in common stock when the common share price is below book value.

The fourth-quarter guidance remains subject to investment performance, financing costs, property-market conditions and other risks identified in NREF’s regulatory filings. The presentation also highlighted near-term life-science supply pressure and noted that its forward-looking portfolio assumptions and distribution coverage estimates may differ from actual results.